Abstract
Pancreatic lipase is a key lipase for triacylglyceride digestion and absorption, which is recognized as a promising target for treatment of metabolic disorders. Natural phytochemicals are hopeful sources for pancreatic lipase inhibitors. The leaves of Artemisia argyi H.Lév. and Vaniot (AL) is commonly used as herbal medicine or food supplement in China and other Asian countries for hundreds of years. AL mainly contains essential oils, phenolic acids, flavonoids and terpenoids, which exhibit many pharmacological activities such as antioxidant, anti-inflammatory, antimicrobial, analgetic, anti-cancer, anti-diabetes and immunomodulatory effects. However, the anti-lipase activity of AL was lack of study and the investigation of anti-lipase ingredients from AL was also insufficient. In the present study, the anti-lipase activity of AL was evaluated in vitro and the potentially pancreatic lipase inhibitors of AL were investigated. High performance liquid chromatography was used to establish fingerprints of AL samples, and fifteen peaks were selected. The anti-lipase activities of AL samples were evaluated by a pancreatic lipase inhibition assay. Then, the spectrum-effect relationships between fingerprints and pancreatic lipase inhibitory activities were investigated to identify the anti-lipase constitutes in AL. As the results, four caffeoylquinic acids, which were identified as neochlorogenic acid, chlorogenic acid, isochlorogenic acid B, and isochlorogenic acid A by high performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry, were selected as potential pancreatic lipase inhibitors in AL. Moreover, anti-lipase activity assessment and molecular docking study of the four compounds were performed to validate the potential lipase inhibitors in AL. The results revealed that the four caffeoylquinic acids in AL as bioactive compounds displayed with anti-lipase activity. The present research provided evidences for the anti-lipase activity of AL, and suggested that some bioactive compounds in AL could be used as lead compounds for discovering of new pancreatic lipase inhibitors.
Highlights
Hyperlipidemia is a chronic, progressive and systemic disease characterized by the lipid metabolism disorders, which is a significant modifiable risk factor for cardiovascular and metabolic diseases (Ray et al, 2019)
The anti-lipase activities of different AL samples were evaluated by pancreatic lipase inhibition assay
Pearson correlation analysis and partial least squares regression (PLSR) results showed a close correlation between fingerprints and anti-lipase activity of AL samples
Summary
Hyperlipidemia is a chronic, progressive and systemic disease characterized by the lipid metabolism disorders, which is a significant modifiable risk factor for cardiovascular and metabolic diseases (Ray et al, 2019). Drug intervention of lipid metabolism provides a credible method for prevention or treatment of metabolic disorders (Zeng et al, 2018). Pancreatic lipase is a key enzyme responsible for hydrolyzing triacylglycerides in the duodenum, which has been discovered as the crucial target that regulates lipid absorption (Hou et al, 2020b). The pancreatic lipase is secreted from the pancreas, and it has been demonstrated that inhibition on pancreatic lipase and regulation of lipid absorption is an effective approach for discovering new agents for treatment of metabolic disorders (Birari and Bhutani, 2007). Orlistat, which is a hydrogenated derivative of lipstatin, is the only approved pancreatic lipase inhibitor so far. Discovery and development of safe and effective pancreatic lipase inhibitors are urgently needed
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.